Watch now!

Along with heating, ventilation, and air conditioning (HVAC), water for injection (WFI) use is responsible for most of the energy consumption, and therefore greenhouse gas (GHG) emissions, in a typical commercial-scale (bio-)pharmaceutical manufacturing facility. Six years into the revision to monograph 0169 of the European Pharmacopoeia allowing methods other than distillation for the generation of WFI, and among the current turmoil in the energy markets, how are the economic and sustainability considerations evolving in critical utility design? This webinar will explore how CAPEX, OPEX, and sustainability factors into the true total cost of ownership (TCO) of WFI generation and distribution in (bio-)pharmaceutical manufacturing. Using distillation-based “hot” vs. membrane-based “cold” WFI generation as a case study, we explain how material flow cost accounting (MFCA) and life cycle inventories (LCIs) are used to conduct realistic and comprehensive life cycle assessments (LCAs) to determine how a (bio-)pharmaceutical manufacturer’s particular use case impacts the TCO, sustainability included.

This webinar, the second in a series on sustainability, tackles sustainability in (bio-)pharmaceutical critical utilities. Join our subject matter expert Christian Lavarreda on this second installment of "Sustainability in Pharma".